|
Helsinki Region, comprising the capital of Finland and its neighbourhood, has “strong innovation for biotechnology, based on its academic quality, vision of leadership and critical mass; the integration of basic and clinical/ translational research; an exciting training environment; strength in classical biotechnology; and access to adequate human resources” – Biotechnology in Finland, Publications of the Academy of Finland 11/02
Strong scientific community
- Large concentration of academic medical, biotechnology and technology faculties and institutionsand research resources
- Four campuses relevant to life sciences
- Knowledge intensive business servicesspecialised in life science sector
- Headquarters of public organisations and regulatory officials supporting life science
Well-established social and health care system
- Well-established hospital system and excellent training of clinicians
- Population records since 1634 and registers of national health care system
- Traditions in epidemiological studies and epidemiological registers
Commercialisation of Innovations
- Innovation chains
- Financing: Academy of Finland, National Technology Agency(TEKES), Finnish National Fund for Research and Development(SITRA) and Venture Capitals
- Critical mass of life science companies
High standard of education
|
|
